×

Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT;serotonin receptor useful for the treatment of disorders related thereto

  • US 8,980,891 B2
  • Filed: 12/16/2010
  • Issued: 03/17/2015
  • Est. Priority Date: 12/18/2009
  • Status: Active Grant
First Claim
Patent Images

1. 3-Methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide hydrate with an XRPD, measured with CuKα

  • radiation, having peaks, in terms of 2θ

    , chosen from those having about the following values;

    5.0998, 18.7064, 19.1157, 19.3029, and 23.6567.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×